Argatroban Injection Cardiovascular Drug Manufacturer

• Customization: Available
• Application: Internal Medicine
• Usage Mode: Injection
• Model NO.: 2ml: 10mg
• Suitable for: Elderly, Adult
• State: Liquid
• Shape: Injection
• Type: Inorganic Chemicals
• Pharmaceutical Technology: Chemical Synthesis
• Transport Package: Carton
• Specification: 2ml: 10mg
• Trademark: SHIMEN
• Origin: Hebei
• HS Code: 3004909099
• Production Capacity: 1000000

Product Description

Argatroban Injection
 

Product Name: Argatroban Injection
Usage and dosage: 1. It is used for the improvement of neurological symptoms (motor paralysis), daily activities (walking, standing, sitting, eating) in patients in the acute phase of ischemic cerebral infarction within 48 hours of onset. The improvement of the daily activities (walking, standing, sitting, eating and drinking).
Usually for adults, 6 doses (60mg of Argatroban) diluted with appropriate amsion are administered once a day in the morning and once in the evening (10mount of infusion are administered intravenously for 24 hours during the first 2 days, and 2 doses (20mg of Argatroban) diluted with appropriate amount of infug of Argatroban) during the next 5 days, and once in 3 hours. It may be increased or decreased according to age and symptoms. Please do so under medical supervision.
2. For the improvement of ulcers, rest pain and coldness in the extremities of patients with chronic arterial occlusive disease (thromboembolic vasculitis, occlusive arteriosclerosis). The usual dosage for adults is one dose (Argatroban 10mg) twice a day (Argatroban 20mg), which is diluted with infusion solution and administered intravenously for 2 to 3 hours each time. The dosage may be increased or decreased according to age and symptoms. Please do so under the guidance of your doctor.
3. Note: For patients with chronic arterial occlusive disease, there is insufficient experience in administering this product for a duration of more than 4 weeks.
Indications1. Used in the acute phase of ischemic cerebral infarction within 48 hours of onset of neurological disorders
2. Used in the improvement of extremity ulcers, rest pain and cold sensation in patients with chronic arterial occlusive disease (thrombo-occlusive vasculitis, occlusive arteriosclerosis)